Program Overview

THE MASTER’S IN TRANSLATIONAL MEDICINE (MTM) PROGRAM PROVIDES OPPORTUNITIES FOR STUDENTS FROM DIVERSE ACADEMIC BACKGROUNDS TO GAIN EXPERTISE IN APPLYING TRANSLATIONAL SCIENCE AND ENGINEERING APPROACHES TO PRODUCE PRACTICAL CLINICAL SOLUTIONS THAT WILL IMPACT HUMAN HEALTH.

 

While industrial and government investment into biomedical research has more than doubled in the past decade, the introduction of practical solutions to unmet clinical needs has lagged dramatically.  It is clear that better training is required to prepare STEM professionals with the skills needed to facilitate the efficient translation of research ideas and engineering solutions into public use for the improvement of human health. Through the MTM program students will learn the science, technology, regulatory, and business skills required to drive scientific discoveries into public use for the improvement of health.

The comprehensive curriculum is meant to be completed in just one year with the central approach being integration of engineering, clinical exposure, research, and entrepreneurship training  in a 3-semester interdisciplinary design-project experiential learning experience – the BioDesign Capstone project. By engaging faculty from across the campus, specifically the Grove School of Engineering and the Sophie Davis School of Biomedical Education/CUNY School of Medicine and collaborating with external partners, our students receive unparalleled training in the process of developing a medical technology and bringing it to market.

CCNY’s Master's in Translational Medicine is the first of its kind to offer the following key benefits:

  • Comprehensive curriculum: We provide training in the key areas involved in bringing a medical technology to market: Biomedical, Clinical Sciences, and Engineering; Clinical Evaluation; and Business Principles and Entrepreneurship.
  • Location: We provide unparalleled access to a network of top-tier clinical partner institutions, including Albert Einstein College of Medicine, CUNY School of Medicine/Sophie Davis Biomedical Education Program, Hospital for Special Surgery, Memorial Sloan Kettering Cancer Center, and Mount Sinai School of Medicine.
  • Hands-on technology development experience: MTM BioDesign projects provide our students with hands-on experience in the development and evaluation of medical technologies.  These projects are sponsored by our external clinical and industrial partners and result in prototypes whose continued development may be pursued beyond the duration of the program.
  • Medical technology industry access: Through independent studies and guest lectures, we offer MTM students with pragmatic industry experience and the opportunity to build their professional networks, both of which are critical for job placement upon completion of the program.
  • Accelerated industry preparation: Our practical training in the process to commercialize medical technologies prepares students to make an immediate impact upon employment in the medical technology industry.

Our students are provided with the tools and skills needed to bring solutions to interdisciplinary biomedical problems to market and with experiential learning opportunities needed to work in inter-disciplinary teams. In building this program from the ground up, we specifically tailored the current curriculum to fit within three core areas to be integrated alongside the 3-semester BioDesign project:

  • Biomedical and Clinical Sciences and Engineering (core and elective) courses designed to prepare students to identify disease targets and understanding how to apply biomedical engineering principals and technologies to create solutions; and
  • Clinical Evaluation courses focused on understanding testing of products in a clinical trial setting; and
  • Business Principles and Entrepreneurship courses that will give students the ability to consider legal, economic, organizational, regulatory, clinical, and technical issues associated with translating knowledge or technology into real-world use.

 

MTM graduates will be uniquely positioned to successfully pursue those projects in industry, start-up or medical environments, and thus increase the rate at which  scientific discoveries and technology innovations can be commercialized for broader clinical and societal use.